Cargando…
Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study
PURPOSE: Proton pump inhibitor (PPI) therapy causes hypergastrinemia, which could promote the development and progression of pancreatic cancer. Accordingly, this study aimed to investigate the association between PPI exposure and the risk of pancreatic cancer. METHODS: We conducted a twelve-year lon...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135510/ https://www.ncbi.nlm.nih.gov/pubmed/30208110 http://dx.doi.org/10.1371/journal.pone.0203918 |